Cathay Biotech Inc. (688065.SS) SHH

47.50

+0.05(+0.11%)

Updated at October 20 11:29AM

Currency In CNY

Valuation

Market Cap22.59B
Enterprise Value19.1B
P/E Ratio62
PEG Ratio0.62
Price/Sales Ratio10.75
Price/Book Ratio1.95
Enterprise/Revenue8.18
Enterprise/EBITDA41.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.17
Operating Margin0.19

Management Effectiveness

Return On Assets0.02
Return On Equity0.04

Income Statement

Revenue2.96B
Revenue/Share4.43
Gross Profit836.44M
EBITDA679.85M
Net Income488.96M
Diluted EPS0.84

Balance Sheet

Total Cash9.82B
Total Cash/Share13.66
Total Debt543.07M
Total Debt/Equity0.03
Current Ratio6.4
Book Value Per Share29.31

Price History

52-Week Change4.29
52-Week High56.16
52-Week Low36.81
Moving Average 50 Days51.74
Moving Average 200 Days48.66

Statistics

Average Volume4.26M
Shares Outstanding721.29M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield0.84
Payout Ratio0.05
Last Split Factor7:5
Last Split DateJuly 20, 2022